Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NAUT - Nautilus Biotechnology Inc


IEX Last Trade
2.6
0.020   0.769%

Share volume: 47,684
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$2.58
0.02
0.78%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
0   0%
1 Month
-2.62%
3 Months
-1.52%
6 Months
-7.14%
1 Year
-18.24%
2 Year
18.72%
Key data
Stock price
$2.60
P/E Ratio 
0.00
DAY RANGE
$2.51 - N/A
EPS 
$0.00
52 WEEK RANGE
$2.19 - $4.00
52 WEEK CHANGE
-$0.24
MARKET CAP 
326.069 M
YIELD 
N/A
SHARES OUTSTANDING 
125.411 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/29/2024
BETA 
1.80
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$55,347
AVERAGE 30 VOLUME 
$61,730
Company detail
CEO:
Region: US
Website:
Employees: 170
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, the company set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. the extraordinary team at nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.

Recent news